Eton Pharmaceuticals, Inc. (ETON) vs Stoke Therapeutics, Inc. (STOK)
A side-by-side comparison of Eton Pharmaceuticals, Inc. and Stoke Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ETON
Eton Pharmaceuticals, Inc.
$55.12HealthcareDelayed quote: Oct 6, 2026, 2:20 PM EDT
STOK
Stoke Therapeutics, Inc.
$24.19HealthcareDelayed quote: Oct 6, 2026, 2:15 PM EDT
Total return — ETON vs STOK
growth of $100 · dividends reinvested · last 7yETON +655.7% (+33.5%/yr)STOK -1.0% (-0.1%/yr)ETON compounded faster over this window
Log scale — wide-divergence pair
ETON STOK
ETON vs STOK: by the numbers
- •STOK is the larger company ($1.56B vs $1.51B market cap).
- •ETON is profitable (12.02% net margin) while STOK runs a net loss (-753.60%).
Metrics side by side
Valuation
| Metric | ETON | STOK |
|---|---|---|
| P/E ratio | 143.32 | N/A |
| Forward P/E | 50.69 | N/A |
| P/S ratio | 14.30 | 56.57 |
| P/B ratio | 32.41 | 4.52 |
| EV / EBITDA | 72.51 | N/A |
| FCF yield | 0.98% | N/A |
Profitability
| Metric | ETON | STOK |
|---|---|---|
| Gross margin | 57.87% | 100.00% |
| Operating margin | 0.09% | -11.16% |
| Net margin | 12.02% | -753.60% |
| ROE | 27.24% | -60.17% |
| ROIC | 20.41% | -63.12% |
Growth (annualized)
| Metric | ETON | STOK |
|---|---|---|
| Revenue CAGR (5Y) | 47.98% | N/A |
| Total return CAGR (5Y) | 63.04% | -0.24% |
Frequently asked
- Is ETON or STOK more profitable?
- ETON runs the higher net margin — ETON at 12.02% versus STOK at -753.60%.
- How have ETON and STOK total returns compared?
- Over the past 5 years, ETON delivered 63.04% and STOK delivered -0.24% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Eton Pharmaceuticals P/E ratioEton Pharmaceuticals ROEStoke Therapeutics ROEEton Pharmaceuticals operating marginStoke Therapeutics operating marginEton Pharmaceuticals revenue growthStoke Therapeutics revenue growthEton Pharmaceuticals free cash flowStoke Therapeutics free cash flow
Eton Pharmaceuticals & Stoke Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.